Question-and-Answer SessionAnd with that, maybe to kick things off, Serge. It's been a unique year with various policy and macro headwinds impacting your end markets. Understanding things have changed meaningfully since the start of the year, how would you sum up the past 9 months for 10x Genomics? And what would you say your hardest achievements in this challenging market?Serge SaxonovCo-Founder, CEO & Director Yes. It has certainly been a pretty eventful year. We started that with a really good momentum. ...